Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
agenus
Sep 24, 2024, 08:55 |
Insight
Benjamin Morin: Novel combinatorial immunotherapy regimen for gliomas
Benjamin Morin shared a post on LinkedIn about a paper by Kwang-Soo Kim et al.…
Sep 15, 2024, 00:29 |
Insight
Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24
Agenus shared on LinkedIn: “Breelyn Wilky, presented new data at ESMO24 highlighting the potential of…
Sep 4, 2024, 11:47 |
Dialogues
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
In this episode of OncoDaily Interviews, Dr. Benjamin Schlechter, a distinguished medical oncologist at the…
Sep 2, 2024, 17:27 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Starting from August 26th, Women’s Equality Day in the United States—a day celebrating the 1920…
Aug 15, 2024, 10:44
OncoDaily Party Barcelona 2024
It's another OncoDaily Party, this time at ESMO. After our successful event at ASCO, complete…
Aug 10, 2024, 13:39 |
Insight
Botensilimab’s effectiveness against tumours poorly responsive to conventional immunotherapy
Justin Stebbing shared a post on LinkedIn: “Congratulations to Dhan Chand and the Agenus team…
Aug 10, 2024, 11:58 |
Insight
Botensilimab: A Revolutionary Fc-Enhanced CTLA-4 Inhibitor Transforming Cancer Immunotherapy
In the rapidly evolving landscape of oncology, we are witnessing remarkable advancements in various treatment…
Aug 9, 2024, 07:16 |
Blog
Botensilimab’s mechanism of action and potential in addressing treatment-resistant cancers
Botensilimab is an investigational human Fc-enhanced CTLA-4 blocking antibody designed to boost both innate and…
Aug 7, 2024, 09:20 |
Blog
Shushan Hovsepyan: Honored to interview Nils Eckardt
Shushan Hovsepyan shared a post by OncoDaily on LinkedIn, adding: ''I had the honor of…
Aug 3, 2024, 06:32 |
Blog
Jennifer S. Buell: A deeply personal fight - the Pan Mass Challenge
Jennifer S. Buell, President and Chief Operating Officer at Agenus, Greater Boston Area shared a…
5
6
7
8
9
All:
112
Posts:
61 - 70
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube